Carvedilol improves endothelium-dependent vasodilation in patients with dilated cardiomyopathy.
Nishioka
Kenji
K
Nakagawa
Keigo
K
Umemura
Takashi
T
Jitsuiki
Daisuke
D
Ueda
Keiko
K
Goto
Chikara
C
Chayama
Kazuaki
K
Yoshizumi
Masao
M
Higashi
Yukihito
Y
D000109:Acetylcholine; D000328:Adult; D000368:Aged; D002227:Carbazoles / Q000627:therapeutic use*; D002311:Cardiomyopathy, Dilated / Q000188:drug therapy* / Q000503:physiopathology; D000077261:Carvedilol; D004730:Endothelium, Vascular / Q000187:drug effects* / Q000378:metabolism / Q000503:physiopathology; D006801:Humans; D008297:Male; D008875:Middle Aged; D009569:Nitric Oxide / Q000378:metabolism; D019001:Nitric Oxide Synthase / Q000037:antagonists & inhibitors; D009599:Nitroprusside; D011412:Propanolamines / Q000627:therapeutic use*; D012039:Regional Blood Flow / Q000187:drug effects; D014665:Vasodilator Agents / Q000627:therapeutic use*; D019323:omega-N-Methylarginine
D002227:Carbazoles; D011412:Propanolamines; D014665:Vasodilator Agents; D000077261:Carvedilol; D009599:Nitroprusside; D019323:omega-N-Methylarginine; D009569:Nitric Oxide; D019001:Nitric Oxide Synthase; D000109:Acetylcholine